159 related articles for article (PubMed ID: 35492074)
21. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of IL-9 and JAK-STAT signaling pathway in children with autism.
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Al-Ayadhi LY; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):472-480. PubMed ID: 28802860
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the effect of ketamine on remifentanil-induced hyperalgesia: a double-blind, randomized study.
Leal PC; Salomão R; Brunialti MK; Sakata RK
J Clin Anesth; 2015 Jun; 27(4):331-7. PubMed ID: 25910532
[TBL] [Abstract][Full Text] [Related]
24. Preemptive analgesia by intravenous low-dose ketamine and epidural morphine in gastrectomy: a randomized double-blind study.
Aida S; Yamakura T; Baba H; Taga K; Fukuda S; Shimoji K
Anesthesiology; 2000 Jun; 92(6):1624-30. PubMed ID: 10839912
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 NL4-3, but not IIIB, inhibits JAK3/STAT5 activation in CD4(+) T cells.
Selliah N; Finkel TH
Virology; 2001 Aug; 286(2):412-21. PubMed ID: 11485409
[TBL] [Abstract][Full Text] [Related]
26. The molecular mechanism of curcumol on inducing cell growth arrest and apoptosis in Jurkat cells, a model of CD4⁺ T cells.
Wang H; Wang Y; Jiang X; Wang Z; Zhong B; Fang Y
Int Immunopharmacol; 2014 Aug; 21(2):375-82. PubMed ID: 24877754
[TBL] [Abstract][Full Text] [Related]
27. Ketamine as an adjuvant to opioids for cancer pain.
Bell R; Eccleston C; Kalso E
Cochrane Database Syst Rev; 2003; (1):CD003351. PubMed ID: 12535471
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer.
Rocha-Zavaleta L; Huitron C; Cacéres-Cortés JR; Alvarado-Moreno JA; Valle-Mendiola A; Soto-Cruz I; Weiss-Steider B; Rangel-Corona R
Cell Signal; 2004 Nov; 16(11):1239-47. PubMed ID: 15337523
[TBL] [Abstract][Full Text] [Related]
29. The effect of combined treatment with morphine sulphate and low-dose ketamine in a prehospital setting.
Johansson P; Kongstad P; Johansson A
Scand J Trauma Resusc Emerg Med; 2009 Nov; 17():61. PubMed ID: 19943920
[TBL] [Abstract][Full Text] [Related]
30. IL-2 enhances cervical cancer cells proliferation and JAK3/STAT5 phosphorylation at low doses, while at high doses IL-2 has opposite effects.
Valle-Mendiola A; Weiss-Steider B; Rocha-Zavaleta L; Soto-Cruz I
Cancer Invest; 2014 May; 32(4):115-25. PubMed ID: 24548303
[TBL] [Abstract][Full Text] [Related]
31. Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer.
Vudattu NK; Magalhaes I; Schmidt M; Seyfert-Margolis V; Maeurer MJ
Int J Cancer; 2007 Oct; 121(7):1512-9. PubMed ID: 17546596
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the effect of ketamine in combination with remifentanil on postoperative pain.
Leal PC; Sakata RK; Salomão R; Sadatsune EJ; Issy AM
Braz J Anesthesiol; 2013; 63(2):178-82. PubMed ID: 24565123
[TBL] [Abstract][Full Text] [Related]
33. Jeg-3 human choriocarcinoma-induced immunosuppression: downregulation of interleukin-2, interleukin-2 receptor alpha-chain, and its Jak/Stat signaling pathway.
Kilic M; Flossmann E; Flossmann O; Vogelsang H; Junker U; Chaouat G; Markert UR
Am J Reprod Immunol; 1999 Jan; 41(1):61-9. PubMed ID: 10097788
[TBL] [Abstract][Full Text] [Related]
34. CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation.
Martín P; Gómez M; Lamana A; Cruz-Adalia A; Ramírez-Huesca M; Ursa MA; Yáñez-Mo M; Sánchez-Madrid F
Mol Cell Biol; 2010 Oct; 30(20):4877-89. PubMed ID: 20696842
[TBL] [Abstract][Full Text] [Related]
35. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.
Warncke T; Stubhaug A; Jørum E
Pain; 1997 Aug; 72(1-2):99-106. PubMed ID: 9272793
[TBL] [Abstract][Full Text] [Related]
36. A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain.
Weinbroum AA
Anesth Analg; 2003 Mar; 96(3):789-795. PubMed ID: 12598264
[TBL] [Abstract][Full Text] [Related]
37. Improved postoperative analgesia with coadministration of preoperative epidural ketamine and midazolam.
Wang X; Xie H; Wang G
J Clin Anesth; 2006 Dec; 18(8):563-9. PubMed ID: 17175423
[TBL] [Abstract][Full Text] [Related]
38. Effect of i.v. ketamine in combination with epidural bupivacaine or epidural morphine on postoperative pain and wound tenderness after renal surgery.
Ilkjaer S; Nikolajsen L; Hansen TM; Wernberg M; Brennum J; Dahl JB
Br J Anaesth; 1998 Nov; 81(5):707-12. PubMed ID: 10193280
[TBL] [Abstract][Full Text] [Related]
39. Adding ketamine to morphine for patient-controlled analgesia after major abdominal surgery: a double-blinded, randomized controlled trial.
Reeves M; Lindholm DE; Myles PS; Fletcher H; Hunt JO
Anesth Analg; 2001 Jul; 93(1):116-20. PubMed ID: 11429351
[TBL] [Abstract][Full Text] [Related]
40. CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.
Ju W; Zhang M; Jiang JK; Thomas CJ; Oh U; Bryant BR; Chen J; Sato N; Tagaya Y; Morris JC; Janik JE; Jacobson S; Waldmann TA
Blood; 2011 Feb; 117(6):1938-46. PubMed ID: 21106989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
